Dermatology Devices Market Size, Share & Trends Analysis Report By Product Type (Diagnostic Device, Treatment Device), By Application (Skin Cancer Diagnosis, Acne, Psoriasis, Skin Rejuvenation, Warts, Others), By End User (Hospitals, Private Clinics, Specialty Dermatology Clinics) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The global dermatology devices market size was valued at USD 12.3 billion in 2022. It is projected to reach USD 33.03 billion by 2031, growing at a CAGR of 11.6% during the forecast period (2023–2031).

Dermatology devices help dermatologists and surgeons diagnose and treat skin disorders. Hospitals, dermatology clinics, physicians, and academic research institutes use these devices. Rising skin diseases and aesthetic procedures drive the global market. This market is expected to grow as developing regions expand their healthcare infrastructure. However, reimbursement issues and medical device regulations are expected to slow market growth. Dermatology devices monitor and diagnose skin, hair, and nail diseases like rashes, hair removal side effects, lesions, sunburn, psoriasis, nail infection, acne, and eczema. Most surgeries leave scars. Dermatology devices are replacing surgery to avoid scars. Dermatology devices help doctors treat skin diseases in hospitals and clinics.

The dermatology devices market is driven by rising skin problems like acne scars, technologically advanced medical devices, skin cancer, healthcare awareness, and non-invasive aesthetic procedures. Advanced, user-friendly, and compact dermatology devices increase demand in clinics and hospitals. Smart algorithms for skin cancer diagnosis, 3D printers for tissue shortages, robotics, and health sensors are dermatology device technologies. Dermatology devices, which diagnose and monitor skin disorders like skin cancer, acne, psoriasis, and eczema, are in demand due to changing lifestyles and diets. Skin cancer is the most common.

Market Dynamics

Global Dermatology Devices Market Drivers

Rising Skin Cancer Rates

Skin cancer and other dermatological illnesses are rising worldwide, driving market expansion. Melanoma kills around 10,130 Americans annually, according to the Skin Cancer Foundation. Artificial sunlamps and intense UV exposure are responsible for the rise in skin cancer. Tanning beds before 35 raises melanoma risk by 75%. One scorching sunburn in infancy or adolescence almost doubles the risk of melanoma. Five severe sunburns between 15 and 20 years raise melanoma risk by 80%. The most significant avoidable risk factor for skin cancer is unprotected sun exposure, which broad-spectrum sunscreens may lower (American Academy of Dermatology). Despite general knowledge of the dangers of tanning and the significance of sunscreens and sun protection, people continue to participate in risky UV radiation-exposing activities.

Growth In Expenditure for R&D

Medical device R&D spending in developed and emerging nations will provide attractive market growth prospects. Tissue regeneration research is also driving market expansion. Dermatology Therapeutic R&D and Technical Innovation discuss innovative targets, disease pathways, the most promising developing medicines, and dermatological drug development's unique obstacles and concerns. Despite scientific prospects, unmet medical needs, and expanding commercial demand, finding novel medicines is difficult. Where should corporations invest in delivering innovative cures to patients? What are dermatological drug development's main problems and considerations?

Global Dermatology Devices Market Restraints

Dermatology Procedure Complications

Dermatology has grown in popularity over the past two decades. Due to the rise in doctors and surgeons offering safe and effective dermatology treatments and the launch of technologically advanced products, aesthetic treatment demand has increased. Dermatology procedures have risks. Aesthetic treatments carry risks and complications. Some risks are: Laser hair removal may darken or lighten skin. These changes may last. Skin lightening primarily affects darker-skinned people who don't avoid the sun. Laser hair removal may cause redness, swelling, and discomfort. After several hours, symptoms usually disappear. Aesthetic treatments can cause anesthesia complications, organ damage, and infections. Red light therapy is considered harmless. RLT units have caused burns and blisters. Some fell asleep with the unit on, while others were burned by damaged wires or gadget corrosion. Red light therapy may require eye protection, even though it is safer than lasers. These issues may hinder dermatology treatment adoption.

Global Dermatology Devices Market Opportunities

Government Funding for Healthcare Infrastructure

The market will grow due to federal funding increases. Additionally, public and private healthcare industry growth, especially in developing economies, will create lucrative market growth opportunities. Air pollution regulations imposed by the government on industries will also benefit the market. A rise in personal disposable income, the introduction of technologically driven products in hospitals, increased investment in developing advanced medical products and devices, and the presence of pollutants like polycyclic aromatic hydrocarbons, oxides, and ultraviolet radiation that damage the skin also boost the market growth.

Regional Analysis

The global dermatology devices market is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA.

North America Dominates the Global Market.

North America is the most significant global dermatology devices market shareholder and is expected to grow at a CAGR of 11.2% during the forecast period. The U.S. and Canada are included in the analysis of the dermatology devices market in North America. The regional market is expected to grow at a steady CAGR, maintaining its dominance. The regional market is growing due to rising rates of skin cancer, eczema, rosacea, and cosmetic procedures. 80% of Americans have acne vulgaris, and 20% have severe acne, which can cause permanent physical and mental scarring, according to the CDC. Psoriasis, melanoma, and skin cancer are common in the area. North American dermatology device demand is expected to rise as consumers become more interested in cosmetic and plastic surgery. The American Society of Plastic Surgeons (ASPS) reported 17.5 million surgical and minimally-invasive cosmetic procedures in 2021, up 2% from 2020. The region's well-organized healthcare infrastructure and health awareness boost the market growth.

Asia Pacific is expected to grow at the fastest CAGR of 12.47% during the forecast period. China, India, Japan, Australia, and the rest of Asia-Pacific are all included in the analysis of the Asia-Pacific dermatology devices market. Due to affordable treatment options, Asia Pacific medical tourism is expected to drive regional market growth. Multinational companies investing in R&D in the Asia Pacific have also driven the regional market. Consumer beauty consciousness will boost product demand and regional market growth. Due to rising living standards, government initiatives to improve healthcare, and rising healthcare spending. Singapore also has more skin cancer cases. In Singapore, 48.6% of men and 51.4% of women develop skin cancer. China will do well in the East Asia dermatology devices market. Laser, dynamic pulse control, radiofrequency, and infrared cosmetic procedures are being introduced.

Segmental Analysis

The market is segmented by product type, application, and end user.

Based on product type, the global dermatology devices market is bifurcated into diagnostic devices and treatment devices. Diagnostic devices are further sub-segmented into imaging devices, dermatoscopes, microscopes, and treatment devices are bifurcated into electrosurgical devices, cryotherapy, laser, and others.

The treatment devices segment is the highest contributor to the market and is expected to grow at a CAGR of 11.57% during the forecast period. Dermatology treatments are widely used. New laser device technologies also contributed to segment growth. Low awareness of novel diagnostic devices may explain their low market share. However, rising skin cancer rates will likely drive segment growth. Laser products were the most widely used treatment devices in 2022 and will grow the fastest over the forecast period. Dermatoscopes dominated diagnostic devices in 2022 due to advanced technologies. Due to rising prevalence and early detection, skin cancer diagnosis is expected to grow over the forecast period. Laser hair removal devices generated the most revenue in 2022 due to their many benefits.

Based on application, the global dermatology devices market is bifurcated into skin cancer diagnosis, acne, psoriasis, skin rejuvenation, warts, and others.

The skin cancer diagnosis segment is the highest contributor to the market and is expected to grow at a CAGR of 12.2% during the forecast period due to rising skin cancer rates that require early detection. In addition, skin cancer diagnosis research for skin conditions will help the segment increase revenue shares in the future. Tattoo removal, resurfacing, and tightening have increased demand for dermatology devices in this segment. In 2022, the International Society of Aesthetic Plastic Surgery reported 21.1%, 76.1%, and 32.3% increases in non-invasive fat reduction, laser hair removal, and photo rejuvenation, respectively. This suggests that the demand for aesthetic treatments is rising, driving the market for technologically advanced and efficient dermatology devices. Laser hair removal devices are safer for all skin tones and hair colors and less painful, driving the segment growth.

Based on end users, the global dermatology devices market is bifurcated into hospitals, private clinics, and specialty dermatology clinics.

The specialty dermatology clinics segment is the highest contributor to the market and is expected to grow at a CAGR of 11.6% during the forecast period. Such facilities' diverse treatment options boost skin disease diagnosis and treatment visits, which boosts segment growth. Clinics will have the highest CAGR from 2023 to 2031. Dermatology clinics treat skin conditions. Certified plastic surgeons provide surgical and nonsurgical dermatology services. TripleTree reported 9,000 U.S. dermatology practices and 14,000 dermatologists. 34% were solo practices, and 48% had three or more doctors. The segment grows as patients seek faster and more effective dermatology treatments at specialty clinics. Due to the global rise in skin cancer and melanoma and the growing number of dermatology clinics, more patients are seeking treatment at dermatology clinics.

Impact of covid-19

The COVID-19 pandemic has caused a global healthcare crisis, resulting in a change in healthcare delivery in most areas. Most unrelated surgeries were postponed in the first half of 2020 to slow the spread of the virus and reduce the strain on healthcare infrastructure. According to Indiana University researchers, healthcare visits declined by approximately 40% in the first six weeks of the pandemic in the U.S, from early March to mid-April.

Following the relaxation of constraints, there has been a general decrease in people postponing seeking care and treatment in healthcare facilities. Furthermore, the slowdown in clinical trial enrollment has pushed back the launch of novel treatments. These considerations may have had a detrimental influence on the autoinjector industry, particularly with its usage in healthcare facilities beginning in early 2020.

However, the overall effect on the autoinjectors market is considered positive, especially during the forecast period, due to several factors. In the biologics space, there has been a shift toward higher delivery volumes and less frequent dosing, which can be achieved through suitably customized autoinjectors.

The COVID-19 pandemic has accelerated the trend of self-injection, allowing patients to be more involved and in charge of their treatment. The trend boosted newer technology in the autoinjector market for improved regulation of injection speed, injection site discomfort, and treatment of anxiety.

Recent Developments

• September 2022, AVITA Medical, Inc., a regenerative medicine company developing and commercializing first-in-class devices and autologous cellular therapies for skin restoration, announced positive topline results from a pivotal randomized, controlled trial evaluating the safety and efficacy of the RECELL System for repigmentation of stable vitiligo lesions.
• In July 2022, Almirall, a global biopharmaceutical company focused on skin health, launched dermatological research collaborations through AlmirallShare, its open innovation platform. This year's edition seeks partnerships for preclinical or clinical skin disease treatments.